| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Progenity Inc (NASDAQ: PROG)
PROG Technical Analysis
5
| As on 8th Jul 2022 PROG SHARE Price closed @ 0.69 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.18 & Strong Sell for SHORT-TERM with Stoploss of 5.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PROGSHARE Price
| Open | 0.69 | Change | Price | % |
| High | 0.71 | 1 Day | 0.00 | 0.00 |
| Low | 0.68 | 1 Week | -0.01 | -1.43 |
| Close | 0.69 | 1 Month | -0.15 | -17.86 |
| Volume | 1472059 | 1 Year | -5.53 | -88.91 |
| 52 Week High 7.31 | 52 Week Low 0.56 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PROG Daily Charts |
PROG Intraday Charts |
Whats New @ Bazaartrend |
PROG Free Analysis |
|
|
PROG Important Levels Intraday
| RESISTANCE | 0.75 |
| RESISTANCE | 0.73 |
| RESISTANCE | 0.72 |
| RESISTANCE | 0.71 |
| SUPPORT | 0.67 |
| SUPPORT | 0.66 |
| SUPPORT | 0.65 |
| SUPPORT | 0.63 |
PROG Forecast April 2024
| 4th UP Forecast | 5.95 |
| 3rd UP Forecast | 4.26 |
| 2nd UP Forecast | 3.22 |
| 1st UP Forecast | 2.18 |
| 1st DOWN Forecast | -0.8 |
| 2nd DOWN Forecast | -1.84 |
| 3rd DOWN Forecast | -2.88 |
| 4th DOWN Forecast | -4.57 |
PROG Weekly Forecast
| 4th UP Forecast | 3.85 |
| 3rd UP Forecast | 2.84 |
| 2nd UP Forecast | 2.21 |
| 1st UP Forecast | 1.58 |
| 1st DOWN Forecast | -0.20 |
| 2nd DOWN Forecast | -0.83 |
| 3rd DOWN Forecast | -1.46 |
| 4th DOWN Forecast | -2.47 |
PROG Forecast2024
| 4th UP Forecast | 14.76 |
| 3rd UP Forecast | 10.25 |
| 2nd UP Forecast | 7.46 |
| 1st UP Forecast | 4.67 |
| 1st DOWN Forecast | -3.29 |
| 2nd DOWN Forecast | -6.08 |
| 3rd DOWN Forecast | -8.87 |
| 4th DOWN Forecast | -13.38 |
Progenity Inc ( NASDAQ USA Symbol : PROG )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PROG Business Profile
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA1/2 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders; and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage; maternal serum screening for chromosomal disorders; and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California. Address: 4330 La Jolla Village Drive, San Diego, CA, United States, 92122
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service